Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease

Authors not listed

Duke University · 2018

Abstract

The purpose of this study is gain a better understanding of a molecule called alpha melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease. Alpha MSH has been shown to have an important role in the regulation of ocular immunity in animal models of inflammatory retinal diseases and retinal dystrophies, and there may be a protective effect of alpha MSH. By studying the levels of alpha MSH in your eye we may better understand its role in advanced dry macular degeneration. By studying the levels of this molecule we hope to better understand if it may be a good target for future treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Anonymous. (2018). The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease. <em>Duke University</em>. https://clinicaltrials.gov/study/NCT03451578
Vancouver
Anonymous. The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease. Duke University. 2018.
BibTeX
@misc{anon2018TheRol, title = {The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease}, author = {Anonymous}, journal = {Duke University}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings